Cite
HARVARD Citation
Irizarry Rovira, A. et al. (2018). Scientific and Regulatory Policy Committee Points to Consider: Histopathologic Evaluation in Safety Assessment Studies for PEGylated Pharmaceutical Products. Toxicologic pathology. pp. 616-635. [Online].